WESTBURY, N.Y., Sept. 9, 2013 /PRNewswire/ — Vasomedical, Inc. (“Vasomedical”) (OTCBB: VASO), a diversified medical technology company specializing in the design, manufacture and sale of medical devices for noninvasive cardiology including EECP® (Enhanced External Counterpulsation) Therapy systems, the gold standard of ECP therapy, announced today that its EECP Therapy has been given a lla Class of Recommendation...
Read More

WESTBURY, N.Y., Aug. 13, 2013 /PRNewswire/ — Vasomedical, Inc. (“Vasomedical”) (OTC BB: VASO) today reported its operating results for the three months ended June 30, 2013. “We are pleased by the continued growth reported for the second quarter of 2013, mostly attributable to the increased activity in our sales representation business in the U.S. and our...
Read More

WESTBURY, N.Y., Aug. 6, 2013 /PRNewswire/ — Vasomedical, Inc. (OTC BB: VASO), announced today that it will release its financial results for the three months ended June 30, 2013 on Tuesday, August 13, 2013. The Company will host a conference call the following day on Wednesday, August 14th at 11:00 a.m. ET featuring remarks by Jun...
Read More

WESTBURY, N.Y., June 3, 2013 /PRNewswire/ — The American Heart Association (AHA) Heart Disease and Stroke 2013 Statistical Update reported that 19.7 million Americans over the age of twenty have physician-diagnosed diabetes, and there are an additional eight million Americans with undiagnosed diabetes. The top causes of disability and death among patients with diabetes are heart disease...
Read More

WESTBURY, N.Y., May 15, 2013 /PRNewswire/ — Vasomedical, Inc. (“Vasomedical”) (OTC BB: VASO) today reported its operating results for the three months ended March 31, 2013. “We are pleased to report that for the first quarter of 2013, we recorded total revenue of $7.3 million, an increase of 21% compared to the same period of...
Read More